ciglitazone has been researched along with Skin Neoplasms in 2 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Skin Neoplasms: Tumors or cancer of the SKIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this report, focusing our attention on ciglitazone, we show that ciglitazone inhibits melanoma growth by inducing apoptosis and cell-cycle arrest, whereas normal melanocytes are resistant to ciglitazone." | 7.75 | In vitro and in vivo anti-melanoma effects of ciglitazone. ( Annicotte, JS; Bahadoran, P; Ballotti, R; Bertolotto, C; Botton, T; Fajas, L; Gozzerino, G; Ortonne, JP; Puissant, A; Rocchi, S; Tartare-Deckert, S; Zamoum, T, 2009) |
| " In this report, focusing our attention on ciglitazone, we show that ciglitazone inhibits melanoma growth by inducing apoptosis and cell-cycle arrest, whereas normal melanocytes are resistant to ciglitazone." | 3.75 | In vitro and in vivo anti-melanoma effects of ciglitazone. ( Annicotte, JS; Bahadoran, P; Ballotti, R; Bertolotto, C; Botton, T; Fajas, L; Gozzerino, G; Ortonne, JP; Puissant, A; Rocchi, S; Tartare-Deckert, S; Zamoum, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botton, T | 1 |
| Puissant, A | 1 |
| Bahadoran, P | 1 |
| Annicotte, JS | 1 |
| Fajas, L | 1 |
| Ortonne, JP | 1 |
| Gozzerino, G | 1 |
| Zamoum, T | 1 |
| Tartare-Deckert, S | 1 |
| Bertolotto, C | 1 |
| Ballotti, R | 1 |
| Rocchi, S | 1 |
| Schadendorf, D | 1 |
2 other studies available for ciglitazone and Skin Neoplasms
| Article | Year |
|---|---|
In vitro and in vivo anti-melanoma effects of ciglitazone.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Re | 2009 |
Peroxisome proliferator-activating receptors: a new way to treat melanoma?
Topics: Antineoplastic Agents; Apoptosis; Humans; Melanoma; PPAR gamma; Signal Transduction; Skin Neoplasms; | 2009 |